<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="for prospective clinical trials to test the post-exposure potential of" exact="hydroxychloroquine" post="against COVID-19 PicotStephanestephane.picot@univ-lyon1.frab⁎MartyAileencBienvenuAnne-LiseadBlumbergLucille H.eDupouy-CametJeanfCarnevalePierregKanoShigeyukihJonesMalcolm K.iDaniel-RibeiroCláudio TadeujMas-ComaSantiagok[a], [b], [c], [d],"/>
 <result pre="for high-quality evaluation protocols of the potential beneficial effect of" exact="hydroxychloroquine" post="(HCQ) as a post-exposure drug for exposed people. In"/>
 <result pre="raised by publicity both regarding the potential beneficial effect of" exact="hydroxychloroquine" post="(HCQ) as well as potential risks from HCQ, we"/>
 <result pre="as a post-exposure drug for exposed people. Keywords COVID19 SARS-CoV2" exact="Hydroxychloroquine" post="Chloroquine Systemic lupus erythematosus Immunomodulation Coronavirus, malaria, antiviral 1"/>
 <result pre="a post-exposure drug for exposed people. Keywords COVID19 SARS-CoV2 Hydroxychloroquine" exact="Chloroquine" post="Systemic lupus erythematosus Immunomodulation Coronavirus, malaria, antiviral 1 Introduction"/>
 <result pre="paucity of clinical evidences of an unequivocal beneficial effect of" exact="chloroquine" post="on COVID-19, the absence of an effective treatment so"/>
 <result pre="far, the untimely publicity given to the potential effect of" exact="chloroquine" post="and the consequent social and political pressure raised the"/>
 <result pre="clinical trials to answer the question: can prophylactic doses of" exact="hydroxychloroquine" post="decrease the risk of clinical infection in documented exposed"/>
 <result pre="for high-quality evaluation protocols of the potential beneficial effect of" exact="hydroxychloroquine" post="(HCQ) as post-exposure drug for exposed people, meaning people"/>
 <result pre="Here we provide information that justifies a clinical trial of" exact="hydroxychloroquine" post="[1] as a post-exposure drug together with the background"/>
 <result pre="the impact of repurposing for patients with inflammatory diseases. 2" exact="Hydroxychloroquine" post="post-COVID-19 exposure: for whom, when, how, why? 2.1 For"/>
 <result pre="inactivate a clinically significant proportion of the virus. 2.4 Why" exact="Hydroxychloroquine" post="is a more soluble hydroxy-analogue of chloroquine (CQ), which"/>
 <result pre="virus. 2.4 Why Hydroxychloroquine is a more soluble hydroxy-analogue of" exact="chloroquine" post="(CQ), which was first synthesized by Hans Andersag in"/>
 <result pre="in endemic areas [5]. In the 1990s studies revealed that" exact="hydroxychloroquine" post="(HCQ), has immunomodulatory properties; leading to its use in"/>
 <result pre="early as the 1990s, researchers noted the antiviral effect of" exact="hydroxychloroquine" post="[7]. Currently, there are over 123 references on PubMed"/>
 <result pre="hydroxychloroquine&quot; similarly, web of science reveals a high interest in" exact="hydroxychloroquine" post="and its role in viral diseases since the early"/>
 <result pre="and its role in viral diseases since the early 1990s." exact="Hydroxychloroquine" post="and chloroquine have demonstrated in vitro antiviral effectiveness against"/>
 <result pre="role in viral diseases since the early 1990s. Hydroxychloroquine and" exact="chloroquine" post="have demonstrated in vitro antiviral effectiveness against Herpes simplex"/>
 <result pre="some studies suggested, at least in vitro, some efficacy of" exact="chloroquine" post="on the SARS-CoV virus [12,13] or MERS-CoV [17]. Using"/>
 <result pre="± 14.8 [19]. More recently, Yao et al. showed that" exact="Hydroxychloroquine" post="(HCQ) was more potent than chloroquine (EC50 = 0.72"/>
 <result pre="et al. showed that Hydroxychloroquine (HCQ) was more potent than" exact="chloroquine" post="(EC50 = 0.72 and EC50 = 5.47 μM respectively)"/>
 <result pre="and EC50 = 5.47 μM respectively) at 48 h [20]." exact="Hydroxychloroquine" post="shows a high partitioning in tissue, including lung and"/>
 <result pre="series study: pre-print, medRxiv not yet peer-reviewed] 25 Feb, 2020)." exact="Hydroxychloroquine" post="penetrates the central nervous system. Patients with glioblastoma were"/>
 <result pre="to diffuse in the brain [27]. Based on this observation," exact="hydroxychloroquine" post="may reach antiviral concentrations in the brain, leading to"/>
 <result pre="which may persist after recovery from COVID-19. 3 Benefits/risks of" exact="hydroxychloroquine" post="against the virus 3.1 Benefits Hydroxychloroquine has a wide"/>
 <result pre="COVID-19. 3 Benefits/risks of hydroxychloroquine against the virus 3.1 Benefits" exact="Hydroxychloroquine" post="has a wide range of indications, including rheumatoid arthritis,"/>
 <result pre="systemic lupus erythematosus, and polymorphous light eruption (Physicians' Desk Reference." exact="Hydroxychloroquine" post="sulfate - Drug Summary. https://www.pdr.net/drug-summary/Plaquenil-hydroxychloroquine-sulfate-1911 (accessed 29 March 2020))."/>
 <result pre="appropriate oral, administration [30]. The risk of retinopathy associated with" exact="hydroxychloroquine" post="treatment has been well documented for decades. It was"/>
 <result pre="but considering the lack of evidence for safety of post-exposure" exact="hydroxychloroquine" post="during pregnancy, we consider that pregnant women should be"/>
 <result pre="antiviral effect of chloroquine/hydroxychloroquine The exact mechanism of action of" exact="chloroquine" post="and hydroxychloroquine against the virus has not been clearly"/>
 <result pre="of chloroquine/hydroxychloroquine The exact mechanism of action of chloroquine and" exact="hydroxychloroquine" post="against the virus has not been clearly depicted; however,"/>
 <result pre="storm that these viruses can generate. 1.Inhibition of viral entry:" exact="Chloroquine" post="interferes with terminal glycosylation of angiotensin-converting enzyme 2 which"/>
 <result pre="the cellular receptor for SARS-CoV-1 and SARS-CoV-2. In cell culture" exact="chloroquine" post="effectively prevents the spread of SARS CoV and works"/>
 <result pre="Experimental data from the Wuhan Institute of Virology demonstrated that" exact="chloroquine" post="inhibits the replication of the SARS-CoV-2, in part because"/>
 <result pre="prevents endocytosis-mediated uptake of SARS-CoV-2. There is also data that" exact="chloroquine" post="interferes with organelle acidification, which may lead to hindering"/>
 <result pre="which may lead to hindering fusion of viral particles, when" exact="chloroquine" post="treatment was used for different emerging or non-emerging virus"/>
 <result pre="H5N1 strain of Influenza A [37]. 3.Reduction of viral infectivity:" exact="Chloroquine" post="inhibits viral particle glycosylation [38]. The envelopes of coronavirus"/>
 <result pre="[40], needed for receptor binding. 4.Immunomodulation: At the cellular level," exact="chloroquine" post="and hydroxychloroquine inhibit immune activation by reducing signaling by"/>
 <result pre="for receptor binding. 4.Immunomodulation: At the cellular level, chloroquine and" exact="hydroxychloroquine" post="inhibit immune activation by reducing signaling by Pattern Recognition"/>
 <result pre="Pattern Recognition Receptors (Toll-like receptor signaling) and cytokine production [1]." exact="Hydroxychloroquine" post="also inhibits the activity of the nucleic acid sensor"/>
 <result pre="preventing TLR signaling and cGAS–stimulator of interferon genes (STING) signaling," exact="hydroxychloroquine" post="can reduce the production of pro-inflammatory cytokines, including type"/>
 <result pre="means to control the outbreak become urgent. The use of" exact="hydroxychloroquine" post="as a post-exposure means to reduce sickness and transmission"/>
 <result pre="to test the hypothesis: ‘Does a post-exposure non-toxic dose of" exact="hydroxychloroquine" post="significantly alter SARS-CoV-2 replication in people exposed to a"/>
 <result pre="strategy for prevention is clearly achievable considering the safety of" exact="hydroxychloroquine" post="for a short period of time, its demonstrated antiviral"/>
 <result pre="of pharmaceutical companies, already ongoing, for increasing the production of" exact="hydroxychloroquine" post="specifically for COVID-19. Other initiative such as the &quot;Defense"/>
 <result pre="References References 1ZhouD.DaiS.-M.TongQ.COVID-19: a recommendation to examine the effect of" exact="hydroxychloroquine" post="in preventing infection and progressionJ Antimicrob Chemother.20 mars 202010.1093/jac/dkaa114"/>
 <result pre="Rheum Dis.201910.1136/annrheumdis-2019-215573Published Online First: 02 May 2019 4TettS.E.CutlerD.J.BeckC.DayR.O.Concentration-effect relationship of" exact="hydroxychloroquine" post="in patients with rheumatoid arthritis--a prospective, dose ranging studyJ"/>
 <result pre="6LandewéR.B.Goei ThèH.S.van RijthovenA.W.BreedveldF.C.DijkmansB.A.A randomized, double-blind, 24-week controlled study of low-dose" exact="cyclosporine" post="versus chloroquine for early rheumatoid arthritisArthritis Rheum. Mai3751994637643 7GoldringJ.P.NemaoraniS.Antimalarial"/>
 <result pre="RijthovenA.W.BreedveldF.C.DijkmansB.A.A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus" exact="chloroquine" post="for early rheumatoid arthritisArthritis Rheum. Mai3751994637643 7GoldringJ.P.NemaoraniS.Antimalarial drugs modulate"/>
 <result pre="Immunopharmacol. Sept2191999599607 8LimaT.L.C.Feitosa DeC.Dos Santos-SilvaE.Dos Santos-SilvaA.M.DaSiqueira E.M.PRLMachadoImproving Encapsulation of Hydrophilic" exact="Chloroquine" post="Diphosphate into Biodegradable Nanoparticles: A Promising Approach against Herpes"/>
 <result pre="metabolites are potent Zika virus inhibitorsJ. Med. Virol.91720191182119030801742 11SavarinoA.Use of" exact="chloroquine" post="in viral diseasesLancet Infect Dis. Sept1192011653654 12VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.Chloroquine is a"/>
 <result pre="infection and spreadVirol J.222 août 20056916115318 13KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob Agents"/>
 <result pre="null, Sahoo GC, Madhukar M, et al.Molecular docking studies of" exact="chloroquine" post="and its derivatives against P23pro-zbd domain of chikungunya virus:"/>
 <result pre="Oct1201020191829818308 15HelalG.K.GadM.A.Abd-EllahM.F.EidM.S.Hydroxychloroquine augments early virological response to pegylated interferon plus" exact="ribavirin" post="in genotype-4 chronic hepatitis C patientsJ. Med. Virol.881220162170217827183377 16SalataC.CalistriA.ParolinC.BaritussioA.PalùG.Antiviral"/>
 <result pre="licensed drugs in human monocyte-derived antigen-presenting cellsPLoS One1332018e0194868 18WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="Vitro Antiviral Activity and Projection of Optimized Dosing Design of" exact="Hydroxychloroquine" post="for the Treatment of Severe Acute Respiratory Syndrome Coronavirus"/>
 <result pre="C-terminal sorting motifsJ Virol. Oct812020071152011525 26RosenfeldM.R.YeX.SupkoJ.G.DesideriS.GrossmanS.A.BremS.A phase I/II trial of" exact="hydroxychloroquine" post="in conjunction with radiation therapy and concurrent and adjuvant"/>
 <result pre="hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant" exact="temozolomide" post="in patients with newly diagnosed glioblastoma multiformeAutophagy. Août108201413591368 27OlafuyiO.BadhanR.K.S.Dose"/>
 <result pre="patients with newly diagnosed glioblastoma multiformeAutophagy. Août108201413591368 27OlafuyiO.BadhanR.K.S.Dose optimization of" exact="chloroquine" post="by pharmacokinetic modeling during pregnancy for the treatment of"/>
 <result pre="in patients with Sjögren syndromeQJM112101 oct 201975776231218368 30KrishnaS.WhiteN.J.Pharmacokinetics of quinine," exact="chloroquine" post="and amodiaquineClinical Implications. Clin Pharmacokinet. Avr3041996263299 31JorgeA.UngC.YoungL.H.MellesR.B.ChoiH.K.Hydroxychloroquine retinopathy -"/>
 <result pre="review of the literatureJ Rheumatol. Déc3812201125042508 33Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
 <result pre="of emerging viral diseasesPharmacol. Res. Perspect.512017e00293 34HuT.Y.FriemanM.WolframJ.Insights from nanomedicine into" exact="chloroquine" post="efficacy against COVID-19Nat Nanotechnol.23 mar 202010.1038/s41565-020-0674-9[Epub ahead of print]"/>
 <result pre="against COVID-19Nat Nanotechnol.23 mar 202010.1038/s41565-020-0674-9[Epub ahead of print] 35MallucciL.Effect of" exact="chloroquine" post="on lysosomes and on growth of mouse hepatitis virus"/>
 <result pre="on growth of mouse hepatitis virus (MHV-3)Virology. Mars2831966355362 36TakanoT.KatohY.DokiT.HohdatsuT.Effect of" exact="chloroquine" post="on feline infectious peritonitis virus infection in vitro and"/>
 <result pre="infection in vitro and in vivoAntiviral Res. Août9922013100107 37YanY.ZouZ.SunY.LiX.XuK.-F.WeiY.Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza a H5N1"/>
 <result pre="glycoproteins into coronavirus virionsViruses743 avr 20151700172525855243 41SchrezenmeierE.DörnerT.Mechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: implications for rheumatologyNat Rev Rheumatol. Mars1632020155166 42LiuJ.CaoR.XuM.WangX.ZhangH.HuH.Hydroxychloroquine,"/>
</results>
